Caspase

CAT # Product Name Tsanangudzo
CPD100616 Emricasan Emricasan, inozivikanwawo seIDN 6556 uye PF 03491390, ndiyo yekutanga-in-class caspase inhibitor mumakiriniki ekuedzwa kwekurapa kwezvirwere zvechiropa. Emricasan (IDN-6556) inoderedza kukuvara kwechiropa uye fibrosis mumurine modhi yeasiri doro steatohepatitis. IDN6556 inogonesa marginal mass islet engraftment mune porcine islet autotransplant modhi. Oral IDN-6556 inogona kuderedza basa reaminotransferase kune varwere vane chirwere chisingaperi chehepatitis C. Inoshandiswa nemuromo-PF-03491390 inochengetwa muchiropa kwenguva yakareba ine yakaderera systemic exposure, ichiita hepatoprotective effect kurwisa alpha-fas-induced chiropa kukuvara mumuenzaniso wembeva. .
CPD100615 Q-VD-Oph QVD-OPH, inozivikanwawo seQuinoline-Val-Asp-Difluorophenoxymethylketone, yakafara spectrum caspase inhibitor ine simba antiapoptotic properties. Q-VD-OPh inodzivirira neonatal sitiroko muP7 rat: basa revakadzi. Q-VD-OPh ine anti-leukemia mhedzisiro uye inogona kudyidzana nevhitamini D analogs kuwedzera HPK1 kusaina mumaseru AML. Q-VD-OPh inoderedza kushungurudzika-induced apoptosis uye inovandudza kudzoreredza kwemashure-enhengo basa mumakonzo mushure mekukuvara kwemusana.
CPD100614 Z-DEVD-FMK Z-DEVD-fmk is cell-permeable, irreversible inhibitor ye caspase-3. Caspase-3 inonzi cysteineyl aspartate-specific protease inoita basa guru muapoptosis.
CPD100613 Z-IETD-FMK MDK4982, inozivikanwawo seZ-IETD-FMK, ine simba, cell-permeable, irreversible inhibitor ye caspase-8 uye granzyme B., The Caspase-8 Inhibitor II inodzora biological chiitiko cheCaspase-8. MDK4982 inonyatso inhibits influenza virus-induced apoptosis mumasero eHeLa. MDK4982 zvakare inhibits granzyme B. MDK4982 ine CAS#210344-98-2.
CPD100612 Z-VAD-FMK Z-VAD-FMK is cell-permeable, irreversible pan-caspase inhibitor. Z-VAD-FMK inhibits caspase processing uye apoptosis induction mu tumor cell in vitro (IC50 = 0.0015 - 5.8 mM).
CPD100611 Belnacasan Belnacasan, inozivikanwawo seVX-765, yakagadzirirwa kuvharidzira Caspase, iri enzyme inodzora chizvarwa chema cytokines maviri, IL-1b uye IL-18. VX-765 yakaratidzwa kuti inhibit acute seizures mu preclinical modhi. Uye zvakare, VX-765 yakaratidza chiitiko mu preclinical modhi yechirwere chepfari. VX-765 yakanga yaiswa muvarwere vanopfuura 100 muchikamu-I uye chikamu-IIa miedzo yemakiriniki ine chokuita nezvimwe zvirwere, kusanganisira 28-day phase-IIa kliniki yekuedza kune varwere vane psoriasis. Yakapedza chikamu chekurapa chechikamu-IIa kliniki yekuedza yeVX-765 iyo yakanyora vangangoita 75 varwere vane kurapa-inodzivirira pfari. Iyo yakapetwa kaviri-mapofu, randomized, placebo-inodzorwa kliniki yekuedza yakagadzirirwa kuongorora kuchengeteka, kushivirira uye kliniki chiitiko cheVX-765.
...

Taura nesu

Inquiry

Latest News

  • Pamusoro 7 Trends MuKutsvaga Kwemishonga Muna 2018

    Epamusoro 7 Mafambiro Mukutsvakurudza Kwemishonga Ini...

    Kuve pasi pekumanikidzwa kunoramba kuchiwedzera kukwikwidza munzvimbo yakaoma yehupfumi uye tekinoroji, makambani emishonga uye ebiotech anofanirwa kuramba achivandudza muzvirongwa zvavo zveR&D kuti varambe vari mberi ...

  • ARS-1620: Inovimbisa inhibitor itsva yeKRAS-mutant cancers

    ARS-1620: Inhibitor itsva inovimbisa yeK...

    Zvinoenderana neongororo yakaburitswa muSero, vaongorori vakagadzira chaiyo inhibitor yeKRASG12C inonzi ARS-1602 iyo yakakonzera kudzoka kwebundu mumakonzo. "Chidzidzo ichi chinopa in vivo humbowo hwekuti mutant KRAS inogona ...

  • AstraZeneca inogamuchira kukwidziridzwa kwemishonga yeoncology

    AstraZeneca inogamuchira kukwidziridzwa kwe ...

    AstraZeneca yakagamuchira kukwidziridzwa kwakapetwa kaviri kweiyo oncology portfolio neChipiri, mushure mekunge US neEuropean regulators vabvuma kutumirwa kwemishonga yavo, danho rekutanga rekuhwina mvumo yemishonga iyi. ...

WhatsApp Online Chat !